Gyre Therapeutics (GYRE) Dividends payables (2022)
Gyre Therapeutics (GYRE) posted quarterly Dividends payables of $7.6 million for Q4 2022.
Gyre Therapeutics (GYRE) Dividends payables (2022) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Dividends payables for 1 consecutive years, with $7.6 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Dividends payables changed N/A year-over-year to $7.6 million; the TTM figure through Dec 2022 stood at $7.6 million (changed N/A YoY), while the FY2022 annual figure was $7.6 million, changed N/A from the prior year.
- Dividends payables steadied at $7.6 million in Q4 2022 per GYRE's latest filing.
- Across five years, Dividends payables topped out at $7.6 million in Q4 2022 and bottomed at $7.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.56 Mn |